Published: Monday, August 22nd, 2016

World first in heart device study at the Golden Jubilee

 gjnh.jpg

The Golden Jubilee National Hospital has become the first in the world to treat a patient with an Implantable Cardioverter Defibrillator (ICD) using a Magnetic Resonance Imaging (MRI) scan as part of the ground-breaking Ready MRI Study.

 

The international study aims to test the safety and effectiveness of the EllipseTM  ICD (developed by St. Jude Medical) in an MRI environment across 60 centres, with 165 patients taking part, and could improve the standard of care for thousands of patients across the globe.

 

Every year across the world, thousands of patients who are at risk of Sudden Cardiac Arrest are fitted with Implantable Cardioverter Defibrillators (ICD), which administer a pulse when they detect potentially life-threatening heart disturbances.

 

The results of this ICD being tested at the Golden Jubilee could allow additional patients around the world at risk of Sudden Cardiac Arrest to safely undergo MRI tests, which would traditionally, not be possible because of the strong magnetic fields involved.

 

Specialists at Scotland’s national hospital have been fitting patients with the revolutionary devices for the last 18 months, but this is the first time they have tested them in an MRI environment.

 

Consultant Cardiologist Dr Roy Gardner is leading the trial at the Golden Jubilee. Dr Gardner said: “Every year, an increasing number of patients are fitted with ICDs. While these devices are often life-saving, they do not allow patients to undergo MRI scans, which are crucial for detecting and monitoring a number of conditions, including signs of a stroke, tumours and complex cardiac abnormalities, which means that these vulnerable patients have to be treated using less detailed imaging systems. 

 

“Recruiting patients to this trial could help provide a better and safer standard of care for patients all across Scotland. It also means we are playing a key role in making these devices available for use in the United States, sharing our knowledge and expertise with other specialist centres to help thousands of individuals suffering from heart conditions every year.

 

“Our first patient’s procedure went very smoothly and provided a great start to an incredibly important project.  As such, we are now about to recruit our 6th patient to this study”

 

The Golden Jubilee National Hospital, part of the Golden Jubilee Foundation, is committed to providing comprehensive bench to bedside care, working alongside its on-site Research Institute to help pioneer new treatments for patients.

 

The home of regional and national heart and lung services for NHS Scotland, the Golden Jubilee has a proven track record in similar projects, playing a key role in the TENDRIL MRI study which was designed to evaluate the safety of conditional pacemakers in MRI scanners.

 

Dr Mike Higgins, Medical Director of the Golden Jubilee National Hospital, commented: “The Golden Jubilee National Hospital is committed to leading quality, research and innovation and this world-leading development is the culmination of a lot of hard work from our team and collaboration with organisations all over the world.

 

“The ability to implant MRI ready pacemakers is a unique innovation that allows us to continue to offer the highest standard of care possible for individuals with complex heart conditions and improve treatment for future generations across the world.”

Golden Jubilee Foundation Logo
Golden Jubilee National Hospital
Golden Jubilee Research Institute logo
Golden Jubilee Innovation Centre Logo
Golden Jubilee Conference Hotel logo